We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Powered COVID-19 CT Algorithm Provides Quantitative Measurement for Suspected Coronavirus Patients

By MedImaging International staff writers
Posted on 03 Dec 2020
Print article
Illustration
Illustration
The latest updated version of an artificial intelligence (AI)-driven COVID-19 medical imaging solution can now help radiologists distinguish between coronavirus and other abnormalities, such as common pneumonia on chest CT scans.

RADLogics (New York, NY, USA) has unveiled the latest version of the company’s AI-Powered COVID-19 CT algorithm. Building on the company’s AI-Powered solution that has processed and analyzed hundreds of thousands of suspected coronavirus cases globally, the latest update delivers a complex deep learning system consisting of several models utilized to detect, localize and segment regions in the lungs infected with COVID-19. The AI-Powered solutions are poised to not only alleviate the increased burden associated with COVID-19, but to help support improved outcomes by reducing burnout and errors.

As part of RADLogics’ latest version of its algorithm, three different analyses can now be performed simultaneously on raw chest CT image scans including: 1) a lungs region-of-interest are cropped with lung abnormalities detected; 2) the lung lobes are segmented and; 3) if the nodules plug-in is activated, focal Ground Glass Opacities (GGOs) are detected. According to leading physicians, these measurements are key features in determining patient classification into COVID-19 and non-COVID-19 indications. The overall system produces the decision whether the case is suspected for COVID-19 with a confidence level (in percentages). These measurements along with other features are used by radiologists to distinguish between COVID-19 and other abnormalities such as common pneumonia.

To further validate the ability of AI to distinguish COVID-19 from other respiratory diseases, members of the RADLogics’ algorithm development team, led by Professor Hayit Greenspan from Tel Aviv University, studied a fully automated AI-based system that takes as input chest CT scans and triages COVID-19 cases. The study explored multiple descriptive features, including lung and infections statistics, texture, shape and location, to train a machine learning-based classifier that distinguishes between COVID-19 and other lung abnormalities (including community acquired pneumonia). The research evaluated the system on a dataset of 2,191 CT cases and demonstrated a robust outcome with 90.8% sensitivity at 85.4% specificity with 94.0% ROC-AUC.

“With the US in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging,” said Moshe Becker, CEO and Co-Founder of RADLogics. “Coronavirus-related infection rates are experiencing a sharp increase in most states - from rural communities to urban areas - that have the potential to overwhelm ER, ICU and radiology teams with a surge of patients, and AI-Powered medical imaging analysis solutions are poised to reduce this pressure through improved patient triage, monitoring and management.”

Related Links:
RADLogics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
New
C-Arm with FPD
Digiscan V20 / V30
New
Ultrasound System
Acclarix AX9

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.